CTRI/2013/10/004101已完成不适用
Cutaneous adverse effects of chemotherapy in cancer patients
Dr Rachel Pavey1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2012年12月15日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- To describe the cutaneous adverse effects of chemotherapy & also its
研究概览
简要总结
This is a prospective,observational study in which 90 cancer patients on chemotherapy presenting with cutaneous adverse effects like alopecia,hyperpigmentation of skin,melanonychia,acne form eruptions,erythema nodosum,etc will be observed & studied.If required a skin biopsy would be done.No drug will be administered in this study
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •patients who give informed consent 2)patients of both sexes & age- 6 yrs & above 3)Patients willing to undergo necessary investigations if required.
排除标准
- •Patients not willing for the study.
- •Patients having a primary skin disease.
- •Patients developing cutaneous manifestations as a result of internal malignancies & not on chemotherapy.
- •Patients on radiotherapy.
结局指标
主要结局
To describe the cutaneous adverse effects of chemotherapy & also its
时间窗: 1 year
frequency severity & distribution in cancer patients
时间窗: 1 year
次要结局
- To describe the cutaneous adverse effects of chemotherapy & also its(frequency severity & distribution in cancer patients)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
skin side effects of anticancer drugs in cancer patientsCTRI/2013/10/004101Dr Rachel Pavey90
进行中（未招募）
不适用
Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast CancerNon-Metastatic Breast CancerNCT02530177Memorial Sloan Kettering Cancer Center546
招募中
不适用
Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic SolutionsNeoplasmsNCT05907551Institut de cancérologie Strasbourg Europe210
尚未招募
不适用
Study of skin related adverse effects of chemotherapy drugs and radiotherapy in cancer patientsCTRI/2023/08/056465-150
已完成
1 期
Phase I/II Study of Chemoprevention With EGFR and COX-2 InhibitorPrecancerous ConditionsNCT00314262Emory University17